Status:
ACTIVE_NOT_RECRUITING
Impact of the COVID-19 Pandemic and HRQOL in Cancer Patients and Survivors
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
COVID-19 Infection
Malignant Solid Neoplasm
Eligibility:
All Genders
Brief Summary
This study uses questionnaires to gain an understanding of how experiences during the COVID-19 pandemic, regardless of COVID-19 status, may have impacted health-related quality of life (HRQOL) and oth...
Detailed Description
PRIMARY OBJECTIVES: I. Assess experiences during the coronavirus disease-2019 (COVID-19) pandemic (e.g., exposure, risk factors, testing, isolation, seropositivity, hospitalization, loss of family or...
Eligibility Criteria
Inclusion
- Prior patients who participated in one of the following protocols: 2012-0112, 2009-0976, or 2005-0035
- Has an active email address or can be contacted via MyChart or personal email
Exclusion
- No evidence of consent from prior clinical trials
Key Trial Info
Start Date :
May 12 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 30 2026
Estimated Enrollment :
1242 Patients enrolled
Trial Details
Trial ID
NCT04447222
Start Date
May 12 2020
End Date
July 30 2026
Last Update
August 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
M D Anderson Cancer Center
Houston, Texas, United States, 77030